CRY - CryoLife, Inc.

NYSE - NYSE Delayed price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 51.02B
Enterprise value 31.23B
Trailing P/E 565.22
Forward P/E 189.66
PEG ratio (5-yr expected) 190.50
Price/sales (ttm)3.68
Price/book (mrq)3.42
Enterprise value/revenue 34.47
Enterprise value/EBITDA 634.88

Trading information

Stock price history

Beta (5Y monthly) 0.75
52-week change 3-9.89%
S&P500 52-week change 315.46%
52-week high 333.00
52-week low 320.76
50-day moving average 329.08
200-day moving average 326.47

Share statistics

Avg vol (3-month) 3186.71k
Avg vol (10-day) 3235.12k
Shares outstanding 537.5M
Float 37.47M
% held by insiders 13.70%
% held by institutions 176.39%
Shares short (30 Jan 2020) 41.33M
Short ratio (30 Jan 2020) 47.96
Short % of float (30 Jan 2020) 44.36%
Short % of shares outstanding (30 Jan 2020) 43.53%
Shares short (prior month 30 Dec 2019) 41.17M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.03
Trailing annual dividend yield 30.11%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 317 Dec 2015
Ex-dividend date 408 Dec 2015
Last split factor 23:2
Last split date 327 Dec 2000

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)30 Dec 2019


Profit margin 0.62%
Operating margin (ttm)6.17%

Management effectiveness

Return on assets (ttm)1.81%
Return on equity (ttm)0.61%

Income statement

Revenue (ttm)276.22M
Revenue per share (ttm)7.44
Quarterly revenue growth (yoy)2.80%
Gross profit (ttm)183.01M
Net income avi to common (ttm)1.71M
Diluted EPS (ttm)0.05
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)33.77M
Total cash per share (mrq)0.86
Total debt (mrq)245.15M
Total debt/equity (mrq)85.81
Current ratio (mrq)4.15
Book value per share (mrq)7.61

Cash flow statement

Operating cash flow (ttm)15.83M
Levered free cash flow (ttm)559.5k